Bio and nanomaterials have increasingly become the cornerstone for the development of novel functional therapeutics in tissue repair and regenerative medicine. However, seamless integration of different disciplines ranging from materials engineering to clinical practices is needed for accelerating discovery and clinical translation. In this special issue, we aim to gather a collection of articles, mini-reviews, and opinions on the present challenges and opportunities bio and nanomaterials offer in the field of regenerative medicine and related therapies. This volume is part of the Virtual Conference and Workshop Series on Bio and Nanomaterials in Tissue Engineering and Regenerative Medicine (BioNTERM). BioNTERM was first virtually held on March 2021 with plenary lectures and workshops covering different, but closely interrelated, topics of bio and nanomaterials in tissue engineering ranging from Science Communication to 3D-bioprinting.
The challenges and limitations for using bio and nanomaterials in regenerative medicine and medical uses need to be properly acknowledged for further advancing in the field. In this special collection, we will critically revised what is needed from a materials, regulatory, and scientific level for further mobilizing bio and nanomaterials to the clinic.
The intrinsic cross-disciplinary nature required for mobilizing bio and nanomaterials to the clinic needs to be better articulated. Clinical translation is a long process and most of the bio and nanomaterials developed for medical uses in labs will not make it to the clinic. The reasons are multi-factorial but failing to comply with regulatory processes, use of non-GMP reagents, toxic precursors, or lack of proper animal/disease models can be listed. In this special issue, we invite researchers to submit cross-disciplinary original articles, mini-reviews, and opinions on how those challenges can be met and how we can further accelerate discovery and innovation of bio and nanomaterials in regenerative medicine.
https://bionterm.com/
Bio and nanomaterials have increasingly become the cornerstone for the development of novel functional therapeutics in tissue repair and regenerative medicine. However, seamless integration of different disciplines ranging from materials engineering to clinical practices is needed for accelerating discovery and clinical translation. In this special issue, we aim to gather a collection of articles, mini-reviews, and opinions on the present challenges and opportunities bio and nanomaterials offer in the field of regenerative medicine and related therapies. This volume is part of the Virtual Conference and Workshop Series on Bio and Nanomaterials in Tissue Engineering and Regenerative Medicine (BioNTERM). BioNTERM was first virtually held on March 2021 with plenary lectures and workshops covering different, but closely interrelated, topics of bio and nanomaterials in tissue engineering ranging from Science Communication to 3D-bioprinting.
The challenges and limitations for using bio and nanomaterials in regenerative medicine and medical uses need to be properly acknowledged for further advancing in the field. In this special collection, we will critically revised what is needed from a materials, regulatory, and scientific level for further mobilizing bio and nanomaterials to the clinic.
The intrinsic cross-disciplinary nature required for mobilizing bio and nanomaterials to the clinic needs to be better articulated. Clinical translation is a long process and most of the bio and nanomaterials developed for medical uses in labs will not make it to the clinic. The reasons are multi-factorial but failing to comply with regulatory processes, use of non-GMP reagents, toxic precursors, or lack of proper animal/disease models can be listed. In this special issue, we invite researchers to submit cross-disciplinary original articles, mini-reviews, and opinions on how those challenges can be met and how we can further accelerate discovery and innovation of bio and nanomaterials in regenerative medicine.
https://bionterm.com/
